Efficacy of leukadherin-1 in the prevention of hyperoxia-induced lung injury in neonatal rats

Jawahar Jagarapu, Jelte Kelchtermans, Min Rong, Shaoyi Chen, Dorothy Hehre, Stefanie Hummler, Mohd Hafeez Faridi, Vineet Gupta, Shu Wu

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Lung inflammation plays a key role in the pathogenesis of bronchopulmonary dysplasia (BPD), a chronic lung disease of premature infants. The challenge in BPD management is the lack of effective and safe antiinflammatory agents. Leukadherin-1 (LA1) is a novel agonist of the leukocyte surface integrin CD11b/CD18 that enhances leukocyte adhesion to ligands and vascular endothelium and thus reduces leukocyte transendothelial migration and influx to the injury sites. Its functional significance in preventing hyperoxiainduced neonatal lung injury is unknown. We tested the hypothesis that administration of LA1 is beneficial in preventing hyperoxiainduced neonatal lung injury, an experimental model of BPD. Newborn rats were exposed to normoxia (21% O2) or hyperoxia (85%O2) and received twice-daily intraperitoneal injection of LA1 or placebo for 14 days.Hyperoxia exposure in the presence of the placebo resulted in a drastic increase in the influx of neutrophils and macrophages into the alveolar airspaces. This increased leukocyte influx was accompanied by decreased alveolarization and angiogenesis and increased pulmonary vascular remodeling and pulmonary hypertension (PH), the pathological hallmarks of BPD. However, administration of LA1 decreased macrophage infiltration in the lungs during hyperoxia. Furthermore, treatment with LA1 improved alveolarization and angiogenesis and decreased pulmonary vascular remodeling and PH. These data indicate that leukocyte recruitment plays an important role in the experimental model of BPD induced by hyperoxia. Targeting leukocyte trafficking using LA1, an integrin agonist, is beneficial in preventing lung inflammation and protecting alveolar and vascular structures during hyperoxia. Thus, targeting integrin-mediated leukocyte recruitment and inflammation may provide a novel strategy in preventing and treating BPD in preterm infants.

Original languageEnglish (US)
Pages (from-to)793-801
Number of pages9
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume53
Issue number6
DOIs
StatePublished - Dec 1 2015

Fingerprint

Hyperoxia
Bronchopulmonary Dysplasia
Lung Injury
Rats
Leukocytes
Integrins
Macrophages
Pulmonary Hypertension
Premature Infants
Lung
Pneumonia
Theoretical Models
Placebos
Pulmonary diseases
Transendothelial and Transepithelial Migration
Infiltration
Vascular Endothelium
Alveolar Macrophages
leukadherin-1
Intraperitoneal Injections

Keywords

  • BPD
  • Hyperoxia
  • Inflammation
  • Integrin
  • LA1

ASJC Scopus subject areas

  • Medicine(all)
  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Clinical Biochemistry
  • Cell Biology

Cite this

Efficacy of leukadherin-1 in the prevention of hyperoxia-induced lung injury in neonatal rats. / Jagarapu, Jawahar; Kelchtermans, Jelte; Rong, Min; Chen, Shaoyi; Hehre, Dorothy; Hummler, Stefanie; Faridi, Mohd Hafeez; Gupta, Vineet; Wu, Shu.

In: American Journal of Respiratory Cell and Molecular Biology, Vol. 53, No. 6, 01.12.2015, p. 793-801.

Research output: Contribution to journalArticle

Jagarapu, Jawahar ; Kelchtermans, Jelte ; Rong, Min ; Chen, Shaoyi ; Hehre, Dorothy ; Hummler, Stefanie ; Faridi, Mohd Hafeez ; Gupta, Vineet ; Wu, Shu. / Efficacy of leukadherin-1 in the prevention of hyperoxia-induced lung injury in neonatal rats. In: American Journal of Respiratory Cell and Molecular Biology. 2015 ; Vol. 53, No. 6. pp. 793-801.
@article{d41746989ee34b9bb1d13c684257b0fb,
title = "Efficacy of leukadherin-1 in the prevention of hyperoxia-induced lung injury in neonatal rats",
abstract = "Lung inflammation plays a key role in the pathogenesis of bronchopulmonary dysplasia (BPD), a chronic lung disease of premature infants. The challenge in BPD management is the lack of effective and safe antiinflammatory agents. Leukadherin-1 (LA1) is a novel agonist of the leukocyte surface integrin CD11b/CD18 that enhances leukocyte adhesion to ligands and vascular endothelium and thus reduces leukocyte transendothelial migration and influx to the injury sites. Its functional significance in preventing hyperoxiainduced neonatal lung injury is unknown. We tested the hypothesis that administration of LA1 is beneficial in preventing hyperoxiainduced neonatal lung injury, an experimental model of BPD. Newborn rats were exposed to normoxia (21{\%} O2) or hyperoxia (85{\%}O2) and received twice-daily intraperitoneal injection of LA1 or placebo for 14 days.Hyperoxia exposure in the presence of the placebo resulted in a drastic increase in the influx of neutrophils and macrophages into the alveolar airspaces. This increased leukocyte influx was accompanied by decreased alveolarization and angiogenesis and increased pulmonary vascular remodeling and pulmonary hypertension (PH), the pathological hallmarks of BPD. However, administration of LA1 decreased macrophage infiltration in the lungs during hyperoxia. Furthermore, treatment with LA1 improved alveolarization and angiogenesis and decreased pulmonary vascular remodeling and PH. These data indicate that leukocyte recruitment plays an important role in the experimental model of BPD induced by hyperoxia. Targeting leukocyte trafficking using LA1, an integrin agonist, is beneficial in preventing lung inflammation and protecting alveolar and vascular structures during hyperoxia. Thus, targeting integrin-mediated leukocyte recruitment and inflammation may provide a novel strategy in preventing and treating BPD in preterm infants.",
keywords = "BPD, Hyperoxia, Inflammation, Integrin, LA1",
author = "Jawahar Jagarapu and Jelte Kelchtermans and Min Rong and Shaoyi Chen and Dorothy Hehre and Stefanie Hummler and Faridi, {Mohd Hafeez} and Vineet Gupta and Shu Wu",
year = "2015",
month = "12",
day = "1",
doi = "10.1165/rcmb.2014-0422OC",
language = "English (US)",
volume = "53",
pages = "793--801",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Efficacy of leukadherin-1 in the prevention of hyperoxia-induced lung injury in neonatal rats

AU - Jagarapu, Jawahar

AU - Kelchtermans, Jelte

AU - Rong, Min

AU - Chen, Shaoyi

AU - Hehre, Dorothy

AU - Hummler, Stefanie

AU - Faridi, Mohd Hafeez

AU - Gupta, Vineet

AU - Wu, Shu

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Lung inflammation plays a key role in the pathogenesis of bronchopulmonary dysplasia (BPD), a chronic lung disease of premature infants. The challenge in BPD management is the lack of effective and safe antiinflammatory agents. Leukadherin-1 (LA1) is a novel agonist of the leukocyte surface integrin CD11b/CD18 that enhances leukocyte adhesion to ligands and vascular endothelium and thus reduces leukocyte transendothelial migration and influx to the injury sites. Its functional significance in preventing hyperoxiainduced neonatal lung injury is unknown. We tested the hypothesis that administration of LA1 is beneficial in preventing hyperoxiainduced neonatal lung injury, an experimental model of BPD. Newborn rats were exposed to normoxia (21% O2) or hyperoxia (85%O2) and received twice-daily intraperitoneal injection of LA1 or placebo for 14 days.Hyperoxia exposure in the presence of the placebo resulted in a drastic increase in the influx of neutrophils and macrophages into the alveolar airspaces. This increased leukocyte influx was accompanied by decreased alveolarization and angiogenesis and increased pulmonary vascular remodeling and pulmonary hypertension (PH), the pathological hallmarks of BPD. However, administration of LA1 decreased macrophage infiltration in the lungs during hyperoxia. Furthermore, treatment with LA1 improved alveolarization and angiogenesis and decreased pulmonary vascular remodeling and PH. These data indicate that leukocyte recruitment plays an important role in the experimental model of BPD induced by hyperoxia. Targeting leukocyte trafficking using LA1, an integrin agonist, is beneficial in preventing lung inflammation and protecting alveolar and vascular structures during hyperoxia. Thus, targeting integrin-mediated leukocyte recruitment and inflammation may provide a novel strategy in preventing and treating BPD in preterm infants.

AB - Lung inflammation plays a key role in the pathogenesis of bronchopulmonary dysplasia (BPD), a chronic lung disease of premature infants. The challenge in BPD management is the lack of effective and safe antiinflammatory agents. Leukadherin-1 (LA1) is a novel agonist of the leukocyte surface integrin CD11b/CD18 that enhances leukocyte adhesion to ligands and vascular endothelium and thus reduces leukocyte transendothelial migration and influx to the injury sites. Its functional significance in preventing hyperoxiainduced neonatal lung injury is unknown. We tested the hypothesis that administration of LA1 is beneficial in preventing hyperoxiainduced neonatal lung injury, an experimental model of BPD. Newborn rats were exposed to normoxia (21% O2) or hyperoxia (85%O2) and received twice-daily intraperitoneal injection of LA1 or placebo for 14 days.Hyperoxia exposure in the presence of the placebo resulted in a drastic increase in the influx of neutrophils and macrophages into the alveolar airspaces. This increased leukocyte influx was accompanied by decreased alveolarization and angiogenesis and increased pulmonary vascular remodeling and pulmonary hypertension (PH), the pathological hallmarks of BPD. However, administration of LA1 decreased macrophage infiltration in the lungs during hyperoxia. Furthermore, treatment with LA1 improved alveolarization and angiogenesis and decreased pulmonary vascular remodeling and PH. These data indicate that leukocyte recruitment plays an important role in the experimental model of BPD induced by hyperoxia. Targeting leukocyte trafficking using LA1, an integrin agonist, is beneficial in preventing lung inflammation and protecting alveolar and vascular structures during hyperoxia. Thus, targeting integrin-mediated leukocyte recruitment and inflammation may provide a novel strategy in preventing and treating BPD in preterm infants.

KW - BPD

KW - Hyperoxia

KW - Inflammation

KW - Integrin

KW - LA1

UR - http://www.scopus.com/inward/record.url?scp=84963838149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963838149&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2014-0422OC

DO - 10.1165/rcmb.2014-0422OC

M3 - Article

VL - 53

SP - 793

EP - 801

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 6

ER -